Showing results (61-70 of 245) with videos related to

Sort By:
Pageof 25
Clinical Genitourinary Cancer|March 13, 2025
CDK4/6 Inhibition With Abemaciclib in Patients With Previously Treated Advanced Renal Cell CarcinomaBradley A McGregor, Wanling Xie, Stephanie A Berg, et al.
Clinical Genitourinary Cancer|October 25, 2007
Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinomaDaniel Cho, Sabina Signoretti, Sandra Dabora, et al.
AJR. American Journal of Roentgenology|June 20, 2008
Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapyAdeel Sabir, Rachel Schor-Bardach, Carol J Wilcox, et al.
Molecular Cancer Therapeutics|August 12, 2010
Renal cancer resistance to antiangiogenic therapy is delayed by restoration of angiostatic signalingRupal S Bhatt, Xiaoen Wang, Liang Zhang, et al.
Nature|July 3, 2008
Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Cancer Discovery|December 22, 2012
Opposing effects of androgen deprivation and targeted therapy on prostate cancer preventionShidong Jia, Xueliang Gao, Sang Hyun Lee, et al.
Journal of Translational Medicine|December 23, 2011
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinomaXiaoen Wang, Liang Zhang, S Nahum Goldberg, et al.
Molecular Cell|March 13, 2012
The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7Adriana E Tron, Takehiro Arai, David M Duda, et al.
Pageof 25